Price Alert

Supernus Pharmaceuticals ... (SUPN)

NASDAQ: SUPN · Real-Time Price · USD

42.38

0.21 (0.50%)

At close: Aug 15, 2025, 9:54 AM

Supernus Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	665.13M	668M	661.82M	651.97M	630.16M	597.4M	607.52M	610.53M	634.01M	668.5M	667.24M	658.96M	630.07M	601.35M	579.77M	564.28M	570.95M	556.35M
Cost of Revenue	97.59M	98.07M	119.36M	134.57M	136.59M	119.05M	105.45M	87.11M	93.38M	92.75M	87.22M	81.26M	73.47M	78.04M	75.06M	76.6M	79.9M	63.26M
Gross Profit	547.45M	549.84M	522.37M	497.32M	493.58M	478.35M	502.07M	523.43M	540.63M	575.75M	580.02M	577.7M	556.6M	523.31M	504.71M	487.68M	491.05M	493.09M
Operating Income	63.13M	70.21M	76.22M	73.8M	41.09M	5.29M	18.41M	33.76M	27.39M	56.32M	64.78M	36.54M	67.38M	90.14M	86.03M	122.93M	146.47M	157.9M
Interest Income	18.03M	17.23M	16.2M	13.21M	10.87M	8.5M	10.45M	10.87M	11.92M	12.34M	21.69M	21.18M	20.65M	21.45M	10.57M	14.4M	14.78M	16.34M
Pretax Income	82.16M	91.8M	97.87M	72.48M	37.42M	-6M	2.77M	36.92M	26.59M	55.04M	60.74M	27.65M	57.06M	76.97M	73.17M	110.82M	134.57M	150.54M
Net Income	64.5M	61.91M	73.86M	59.71M	5.24M	-15.51M	1.32M	25.62M	43.35M	52.04M	60.71M	37.67M	57.48M	73.35M	53.42M	81.75M	100.19M	111.13M
Selling & General & Admin	333.66M	325.01M	321.58M	323.45M	336.4M	337.28M	336.36M	329.05M	358.67M	372.36M	377.22M	404.98M	364.7M	333.76M	304.76M	259.52M	242.15M	220.72M
Research & Development	105.62M	109.59M	106.98M	101.68M	95.3M	94.09M	90.99M	86.02M	82.92M	74.92M	74.55M	77.86M	77.96M	77.03M	90.47M	87.33M	84.51M	91.3M
Other Expenses	46.05M	46.05M	18.6M	n/a	n/a	n/a	19.97M	40.66M	61.31M	61.31M	61.99M	53.31M	38.68M	44.63M	29.99M	16.26M	9.65M	7.03M
Operating Expenses	485.33M	480.65M	447.17M	424.53M	452.94M	472.72M	488.66M	497.08M	523M	529.24M	534.4M	556.8M	501.98M	455.41M	425.21M	370.7M	350.62M	332.47M
Interest Expense	n/a	n/a	n/a	n/a	n/a	910K	2.42M	4.01M	5.73M	6.63M	7.07M	11.41M	15.61M	19.27M	23.42M	23.59M	23.75M	24.1M
Selling & Marketing Expenses	66.7M	125.5M	158.97M	193.25M	230.43M	231.52M	229.19M	221.9M	250.82M	264.5M	267.79M	281.98M	246.98M	221.78M	199.71M	174.12M	162.59M	144.16M
Cost & Expenses	601.99M	597.79M	585.6M	578.17M	589.53M	591.77M	594.12M	584.19M	616.38M	621.99M	621.62M	638.06M	575.45M	533.45M	500.28M	447.3M	430.52M	395.73M
Income Tax Expense	17.67M	29.88M	24M	12.77M	32.19M	9.5M	1.45M	11.3M	-16.76M	2.99M	32K	-10.02M	-427K	3.62M	19.75M	29.07M	34.38M	39.42M
Shares Outstanding (Basic)	56.02M	55.87M	55.47M	55.15M	54.98M	54.8M	54.65M	54.61M	54.5M	54.38M	54.1M	53.79M	53.43M	59.35M	53.24M	53.19M	53.01M	52.93M
Shares Outstanding (Diluted)	56.64M	55.87M	56.47M	56.02M	55.72M	55.63M	55.3M	54.61M	54.5M	62.45M	62.09M	55.03M	61.4M	61.41M	54.53M	54.33M	54.72M	54.2M
EPS (Basic)	1.17	1.13	1.34	1.08	0.09	-0.28	0.03	0.47	0.80	0.96	1.08	0.66	1.04	1.34	1.02	1.55	1.90	2.11
EPS (Diluted)	1.15	1.11	1.32	1.07	0.09	-0.28	0.01	0.39	0.72	0.87	1.00	0.63	1.00	1.29	0.98	1.51	1.85	2.07
EBITDA	166.03M	166.97M	165.68M	161.12M	125.63M	91.2M	98.83M	116.29M	109.81M	138.96M	138.83M	101.41M	119.84M	129.55M	129.19M	162.65M	185.34M	190.59M
EBIT	85.4M	95.03M	97.87M	90.48M	53.22M	10.7M	13.98M	31.73M	25.33M	53.63M	52.73M	23.99M	57.59M	82.2M	96.6M	134.4M	158.32M	174.64M
Depreciation & Amortization	80.65M	80.04M	80.4M	83.23M	84.99M	84.99M	84.84M	84.56M	84.48M	85.33M	86.09M	77.42M	62.25M	47.34M	32.59M	25.38M	26.62M	23.02M